According to the latest report by IMARC Group, “Global Hydrocephalus Shunts Market Size, Share, Growth, Industry Trends, Opportunity and Forecast 2023-2028“, the global hydrocephalus shunts market reached US$ 433.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 561.8 Million by 2028, exhibiting a growth rate (CAGR) of 3.99% during 2023-2028.
Hydrocephalus shunts are medical devices used to treat a condition that occurs when cerebrospinal fluid (CSF) builds up in the ventricles of the brain. They are commonly available in catheters, adjustable pressure valves, and fixed pressure valve variants. These devices comprise an inflow or proximal catheter that drains CSF from the lateral ventricles, a valve mechanism that regulates intracranial pressure by controlling fluid flow, and an outflow or distal catheter that runs under the skin and directs CSF. In addition, they are placed into the brain to relieve the tension on the cerebrum that returns the brain’s enlarged ventricles to their actual size. Owing to these properties, hydrocephalus shunts are widely adopted across the healthcare sector.
Request Free Sample Report: https://www.imarcgroup.com/hydrocephalus-shunts-market/requestsample
Market Trends:
The market is primarily driven by the increasing prevalence of brain and neurological disorders among individuals, especially the geriatric population. Hydrocephalus shunts are extensively used due to the rising occurrence of congenital abnormalities, brain and nerve injuries, accidents leading to central nervous system (CNS) defects, and lifestyle diseases. In addition, the escalating product demand to treat hydrocephalus among infants that could lead to enlargement of the head and damage to the brain represents another significant growth-inducing factor.
Moreover, various technological advancements, including the development of anti-siphon devices that assist in avoiding siphon effects over cerebrospinal fluid and programmable valves for controlling the flow of cerebrospinal fluid to prevent it from moving in the wrong direction are providing a positive thrust to market growth. Furthermore, the developing healthcare industry and the implementation of various government initiatives to spread awareness regarding hydrocephalus shunts are anticipated to propel market growth.
Click here to view detailed information with table of content: https://www.imarcgroup.com/hydrocephalus-shunts-market
Global Hydrocephalus Shunts Market 2023-2028 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Hydrocephalus Shunts Companies:
Kaneka Medix Corporation (Kaneka Corporation), Medtronic Plc, Natus Medical Incorporated, Argi Group, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd., HLL Lifecare Limited, Integra LifeSciences, Sophysa, Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH) and TKB Corporation.
The report has segmented the market on the basis of type, product type, age group, end user and region.
Breakup by Type:
- Ventriculo-Peritoneal
- Ventriculo-Atrial
- Ventriculo-Pleural
- Lumbo-Peritoneal
Breakup by Product Type:
- Hydrocephalus Valves
- Adjustable Pressure Valves
- Fix Pressure Valves
- Hydrocephalus Catheters
Breakup by Age Group:
- Infants
- Children
- Adults
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Ask an Analyst: https://www.imarcgroup.com/request?type=report&id=5226&flag=C
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group